Market Overview

Clovis Oncology Announces 2014 Objectives, Financial Guidance


Clovis Oncology (NASDAQ: CLVS) today announced anticipated
development milestones and financial guidance for 2014. Clovis currently
has three clinical development programs underway, and expects to
initiate four registration studies for two of its programs during the
first half of 2014.

See full press release

Posted-In: News Guidance Contracts Management Global


Related Articles (CLVS)

View Comments and Join the Discussion!